Guanidyl-containing artemisinin derivates and application thereof

A derivative, dihydroartemisinin technology, applied in the field of medicine, can solve the problem of weak non-small cell lung cancer cell activity

Inactive Publication Date: 2011-04-13
SHENYANG PHARMA UNIVERSITY
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

When studying the anticancer activity of artesunate on 55 cancer cell lines, Eferth et al. found that artesunate had the strongest anticancer activity on leukemia cells and colon cancer cells, and had the strongest antica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Guanidyl-containing artemisinin derivates and application thereof
  • Guanidyl-containing artemisinin derivates and application thereof
  • Guanidyl-containing artemisinin derivates and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to artemisinin derivates as shown in a general formula I, optically active isomers and pharmaceutically acceptable salts thereof, wherein the substituents R1, R2, X and Ar have the meanings defined in the specification. The invention also relates to application of the compound shown in general formula I in the preparation of medicaments for treating and/or preventing cancer.

Description

technical field The invention belongs to the technical field of medicine, and relates to new artemisinin derivatives and their optically active bodies, and their pharmaceutically acceptable salts, their preparation methods and pharmaceutical compositions containing the compounds. The present invention also relates to the use of the derivative in the preparation of medicines for treating and / or preventing cancer and other proliferative diseases. Background technique Cancer is a disease that seriously threatens human life. According to the statistics of WHO in 2008, the number of cancer deaths in 2007 reached 7.9 million, accounting for about 13% of all deaths. In recent years, with the deepening of the research on the mechanism of tumorigenesis, the molecular mechanism of the occurrence and development of cancer has been continuously revealed, and anti-tumor drugs have developed from the initial cytotoxic drugs to the research on drugs that act on tumor-specific targets. Ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D493/20C07D519/00A61K31/453A61K31/357A61K31/5377A61K31/4025A61K31/496A61P35/00A61P35/02
Inventor 宫平赵燕芳翟鑫刘亚婧
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products